Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Why ConvaTec needs to clarify the extent of its supply crisis
Supply issues and a fall in full year revenue growth toppled ConvaTec’s (CTEC) shares late last year, leaving the wound care specialist trading below the 225p price at which it joined the stock market in October 2016.
Shares in ConvaTec are now trading at 188.65p. The company publishes its half year results on 15 February.
Management need to spell out when ConvaTec can resolve its supply problems in its advanced wound and ostomy care division can be resolved.